The largest database of trusted experimental protocols

Atp assay bioluminescence detection kit

Manufactured by Beyotime

The ATP assay bioluminescence detection kit is a tool used to quantify the presence of adenosine triphosphate (ATP) in biological samples. The kit utilizes a luciferase-based reaction to generate a luminescent signal proportional to the ATP concentration, allowing for sensitive and rapid detection of this essential energy-carrying molecule.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using atp assay bioluminescence detection kit

1

Quantifying Tissue and Blood ATP Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood from normotensive and hypertensive mice was collected at different time points. Plasma was prepared by spinning the whole blood at 1500g for 15 min and collecting the supernatant. ATP levels were determined with an ATP assay bioluminescence detection kit (Beyotime). For testing tissue ATP release, aorta and renal artery were removed from PBS-perfused mice and cultured in 30 μl of RPMI 1640 for 3 hours. To measure ATP production by blood cells, 50 μl of whole blood was centrifuged at 300g for 5 min to remove plasma. Blood cells were resuspended in 50 μl of RPMI 1640 and transferred into a fresh well for a 3-hour incubation. After 3 hours, the culture plates containing blood cells or tissue were centrifuged at 300g for 5 min and supernatants were then collected for ATP measurement.
+ Open protocol
+ Expand
2

Plasma ATP Levels in Hypertension

Check if the same lab product or an alternative is used in the 5 most similar protocols
Zhejiang Hospital and the Fourth Affiliated Hospital of Zhejiang University reviewed and approved the human studies. All the participants signed a written informed consent form before being enrolled in the study. Patients with a history of hypertension between 40 and 70 years of age and normotensive controls were recruited. Their BP was measured on two consecutive days. Patients were assigned to the HTN group when either average SBP was ≥140 mmHg or average DBP was ≥90 mmHg. Hypertensive patients (by history) who were taking anti-hypertensive medications and had both average SBP below 140 mmHg and average DBP below 90 mmHg were assigned to the C-HTN group. The NTN group is normotensive controls with normal measured BP and no previous history of hypertension. Patients with histories of autoimmune diseases, lung diseases, asthma, stroke, AIDS, cancer, and transplantation and those having symptoms or history of infection in the last month were excluded. Whole blood of selected subjects was collected into heparin-treated anticoagulation tubes. Plasma was isolated by centrifuging the whole blood at 1000g for 15 min. Hemolyzed samples were not used. All blood samples used were not subjected to a freeze-thaw cycle at any step in the process. Plasma ATP levels were assessed with an ATP assay bioluminescence detection kit (Beyotime).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!